AzTrials
AzTrials

in Situ SimulationNCT07346937

Evaluating the Impact of In-Situ Simulation on Interprofessional Healthcare Team Training

A study testing In Situ Simulation and Simulation Center in people with in Situ Simulation and Simulation in Training Center, run by Universidade do Porto at 2 sites in Portugal.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Clinical simulation has established itself as an essential methodology in healthcare training, enabling the development of technical and non-technical skills in controlled and safe environments. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
In Situ Simulation and Simulation Center
Could I receive a placebo?
No, everyone receives an active treatment
How many people
108 participants
Where
2 sitesPortugal
Study dates
Feb 2026to 31 Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Professionals working in the surgical center of ULSM-HPH with at least 6 months of experience in the role.
  • Availability to participate in the simulation group assigned to them.

Who cannot join

  • Professionals who do not work in the surgical center.
  • Participants who cannot complete all phases of the study due to scheduling or health restrictions.
  • Pregnant professionals.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Maria do Céu F Campos contact

mariaceucampos@gmail.com

Portugal2 sites
  • ULS Matosinhos - Hospital Pedro Hispano

    Matosinhos Municipality, 4464-513

    Maria do Céu F Campos, +351 964 131 846, mariaceucampos@gmail.com

    Rita Resende, MD, ritaresende@yahoo.com

  • Faculty of Medicine, University of Porto

    Porto, 4200-319

    Maria do Céu F Campos, +351 964 131 846, mariaceucampos@gmail.com

    Abel Nicolau, PhD, anicolau@med.up.pt

Other trials in Portugal

About this study

Official title: Evaluating the Impact of In-Situ Simulation on Interprofessional Healthcare Team Training: A Randomized Trial

Clinical simulation has established itself as an essential methodology in healthcare training, enabling the development of technical and non-technical skills in controlled and safe environments. This study proposes a randomized trial that compares the impact of two learning contexts-a simulation center and the in situ simulation (ISS) environment in the operating room-on the training of interprofessional teams. The aim is to evaluate the effectiveness and efficiency of each context in the acquisition and performance of technical and non-technical skills, as well as participants' perceptions of realism, teamwork, and patient safety. The randomized experimental design reinforces the methodological rigor and internal validity of the results, allowing the identification of important differences between the two approaches. The scarcity of studies on interprofessional simulation in a real clinical context underscores the relevance of this research, which may provide scientific evidence to guide training policies and promote safer, more collaborative practices. It is expected that the results will contribute to improving interprofessional training programs and supporting the systematic integration of ISS in the healthcare field, especially in high-complexity environments.

Read the detailed description

The increasing complexity of healthcare and the need for a coordinated response among different professionals make interprofessional teamwork an essential element for patient safety and quality of care. In this context, clinical simulation has established itself as a fundamental teaching and learning methodology, allowing the training of technical and non-technical skills in controlled and safe environments. Among the different simulation modalities, in situ simulation (ISS) has gained prominence because it occurs in the clinical context itself, involving real teams and resources of the hospital environment. This approach favors the identification of latent threats to safety and the analysis of workflows and communication in high-pressure scenarios. In addition, ISS has demonstrated a positive impact on safety culture and the performance of multidisciplinary teams. Several studies support that simulation based on interprofessional teams promotes mutual understanding of roles, respect between disciplines, and effective coordination during critical situations. The integration of professionals from different areas in realistic scenarios enhances collaborative learning and strengthens communication, leadership, and decision-making skills, central aspects of Non-Technical Skills (NTS). Despite the available evidence, there is still a gap in the literature regarding the direct comparison between simulation in a training center and ISS in the hospital setting, particularly in the surgical center, an environment characterized by professional interdependence and high technical complexity. Thus, this study proposes a randomized trial comparing the impact of ISS and simulation in a training center on the formation of interprofessional teams. The aim is to systematically evaluate the effect of each context on the acquisition and performance of technical and non-technical skills, as well as on professionals' perception of realism, training effectiveness, and patient safety. This study, therefore, aims to contribute to the development of more effective training strategies based on scientific evidence.

Being tested
In Situ Simulation, Simulation Center
Keywords
In Situ Simulation, Simulation Center, Interprofessional Team Training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • In Situ SimulationOther

    Simulation scenario carried out in situ. The training team will consist of 3 facilitators (who will always be the same throughout the study), with each scenario having only 2 facilitators and the principal investigator.

    Each group will be subjected to the same simulation scenario, the process of which is approximately 60 minutes, divided into: Briefing - 10 min; Scenario Development - 15 minutes; Debriefing - 30/35 min.

  • Simulation CenterOther

    Simulation scenario carried out in the Simulation Center. The training team will consist of 3 facilitators (who will always be the same throughout the study), with each scenario having only 2 facilitators and the principal investigator.

    Each group will be subjected to the same simulation scenario, the process of which is approximately 60 minutes, divided into: Briefing - 10 min; Scenario Development - 15 minutes; Debriefing - 30/35 min.

Study groups in NCT07346937
Study groupRoleWhat they receive
In Situ SimulationExperimentalHalf of the teams will carry out the scenario in an in-situ context, at the ULS Matosinhos - Pedro Hispano Hospital (ULSM-HPH).
Receives: Other: In Situ Simulation
Simulation CenterActive comparatorHalf of the teams will carry out the scenario in a Simulation Center context, at the Faculty of Medicine, University of Porto (SIMFMUP).
Receives: Other: Simulation Center

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Simulation Effectiveness (SET-M)

    Measured with Simulation Effectiveness Tool - Modified (SET-M). SET-M is a 19-item tool with a three-point Likert scale that measures effectiveness by capturing student feedback on three domains.

    The higher the score, the more effective the simulation training.

    Measured: Immediately after the simulation session (Day 1)

  2. Simulation Effectiveness (ICCAS)

    Measured with the Interprofessional Collaborative Competencies Attainment Survey (ICCAS).

    ICCAS is a 20-item self-report tool with a seven-point Likert scale that evaluates the participants' competencies in six dimensions before and after the simulation. Participants complete the tool after simulation training, but rate their abilities twice: once as they recall them before training, and after that training is done.

    The higher the score, the more effective the simulation training.

    Measured: Immediately after the simulation session (Day 1)

  3. Simulation Design Evaluation

    Evaluated using Simulation Design Scale (SDS) - Student version. SDS is a 20-item tool with a five-point Likert scale designed to evaluate five design features of instructor-developed simulations.

    The instrument has two parts: the presence of specific features in the simulation and the importance of those features to the learner.

    The higher the score, the higher the evaluation of the design feature.

    Measured: Immediately after the simulation session (Day 1)

  4. Simulation Debriefing Assessment

    Measured with the Debriefing Assessment for Simulation in Healthcare (DASH) Short version for students and for instructors.

    DASH for students has students evaluating the instructors in 6 elements with a seven-point Likert scale, while DASH for instructors is a self-assessment tool with the same structure.

    The higher the score, the higher the debriefing skill.

    Measured: Immediately after the simulation session (Day 1)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jan 2026
  2. Study startFeb 2026 (estimated)
  3. Primary completionMay 2026 (estimated)
  4. Study completion31 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
108 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07346937
Sponsor's protocol ID
In-Situ Simulation
Status last verified
Dec 2025
First submitted
10 Dec 2025
Last updated
16 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing In Situ Simulation and Simulation Center in people with in Situ Simulation and Simulation in Training Center, run by Universidade do Porto at 2 sites in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 16 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Janete Santos, PhD (+351 220 426 569, investigaclinica@med.up.pt), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Simulation Effectiveness (SET-M) (time frame: Immediately after the simulation session (Day 1)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in